FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder

BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.

Enterprise buyers and decision-makers should pay attention — this could impact AI procurement and implementation strategies across industries.

Why it matters for your wallet: Every major AI industry move creates earning opportunities — from new tools to invest in, skills to learn, or markets to enter. Tracking these developments is how you stay ahead.

Read the full story on TechCrunch →